Comparative evaluation of synergy of combinations of -lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae
Open Access
- 3 February 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 66 (4), 845-849
- https://doi.org/10.1093/jac/dkr016
Abstract
Streptococcus pneumoniae has shown a great ability to develop efficacious mechanisms of resistance to the main drugs for the treatment of pneumonia, such as β-lactams, macrolides and fluoroquinolones. The present study aimed to compare the antipneumococcal activity of combinations of respiratory fluoroquinolones with cephalosporins (either parenteral or oral) or protected penicillin versus the standard combinations (i.e. a macrolide with a protected penicillin or cephalosporin) against 100 isolates with different susceptibilities to macrolides and/or penicillin. Chequerboard assays for all isolates and time–kill curves for nine isolates with different patterns of susceptibility were performed. Synergy between antibiotics at serum peak concentrations was also determined. The combination of levofloxacin with ceftriaxone produced the highest rate of synergy (54/100), mainly against macrolide-resistant strains (22/30). Antagonism was not observed for any tested combination apart from clarithromycin with amoxicillin/clavulanic acid (22/100 isolates). Although the killing activities of all antibiotics improved when they were tested in combination, synergy was observed only for some combinations after 12 and/or 24 h. Serum concentrations were effective in inhibiting the growth of the tested strains. Combinations of levofloxacin with parenteral cephalosporins were the most active among all the tested combinations, while antagonism occurred when clarithromycin and amoxicillin/clavulanic acid were tested.Keywords
This publication has 22 references indexed in Scilit:
- Burden of Community-Acquired Pneumonia in North American AdultsPostgraduate Medicine, 2010
- Community-Acquired Pneumonia: The U.S. PerspectiveSeminars in Respiratory and Critical Care Medicine, 2009
- Comparison of β-Lactam and Macrolide Combination Therapy versus Fluoroquinolone Monotherapy in Hospitalized Veterans Affairs Patients with Community-Acquired PneumoniaAntimicrobial Agents and Chemotherapy, 2007
- Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999–2003)International Journal of Antimicrobial Agents, 2005
- Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococciJournal of Antimicrobial Chemotherapy, 2004
- Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?Diagnostic Microbiology and Infectious Disease, 2003
- Synergy, antagonism, and what the chequerboard puts between themJournal of Antimicrobial Chemotherapy, 2003
- Lack of Synergy of Erythromycin Combined with Penicillin or Cefotaxime against Streptococcus pneumoniae In VitroAntimicrobial Agents and Chemotherapy, 2003
- A Brief History of the Pneumococcus in Biomedical Research: A Panoply of Scientific DiscoveryClinical Infectious Diseases, 1993
- Clinical Pharmacokinetics of CeftriaxoneClinical Pharmacokinetics, 1989